Safety Assessment of Cumulative Dose of Combivent(R) HFA-propelled Metered Dose Inhaler in Comparison to Combivent(R) CFC-propelled Metered Dose Inhaler. A Randomised, Double-blind, Active-controlled, Two-way Cross-over Study in COPD Patients

Trial Profile

Safety Assessment of Cumulative Dose of Combivent(R) HFA-propelled Metered Dose Inhaler in Comparison to Combivent(R) CFC-propelled Metered Dose Inhaler. A Randomised, Double-blind, Active-controlled, Two-way Cross-over Study in COPD Patients

Discontinued
Phase of Trial: Phase II

Latest Information Update: 25 Jul 2014

At a glance

  • Drugs Salbutamol/ipratropium bromide (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Boehringer Ingelheim
  • Most Recent Events

    • 25 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top